These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29143498)

  • 21. The cost of influenza-associated hospitalizations and outpatient visits in Kenya.
    Emukule GO; Ndegwa LK; Washington ML; Paget JW; Duque J; Chaves SS; Otieno NA; Wamburu K; Ndigirigi IW; Muthoka PM; van der Velden K; Mott JA
    BMC Public Health; 2019 May; 19(Suppl 3):471. PubMed ID: 32326937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The economic burden of influenza among adults aged 18 to 64: A systematic literature review.
    de Courville C; Cadarette SM; Wissinger E; Alvarez FP
    Influenza Other Respir Viruses; 2022 May; 16(3):376-385. PubMed ID: 35122389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.
    Baral R; Nonvignon J; Debellut F; Agyemang SA; Clark A; Pecenka C
    BMC Public Health; 2020 May; 20(1):619. PubMed ID: 32370763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach.
    Sruamsiri R; Ferchichi S; Jamotte A; Toumi M; Kubo H; Mahlich J
    Influenza Other Respir Viruses; 2017 Nov; 11(6):543-555. PubMed ID: 28987034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
    Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
    Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The financial burden of an influenza outbreak in a small rehabilitation centre.
    Sendi P; Dräger S; Batzer B; Walser S; Dangel M; Widmer AF
    Influenza Other Respir Viruses; 2020 Jan; 14(1):72-76. PubMed ID: 31651074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic Burden of Influenza in Thailand: A Systematic Review.
    Kiertiburanakul S; Phongsamart W; Tantawichien T; Manosuthi W; Kulchaitanaroaj P
    Inquiry; 2020; 57():46958020982925. PubMed ID: 33355022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
    Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
    PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying the direct secondary health care cost of seasonal influenza in England.
    Moss JWE; Davidson C; Mattock R; Gibbons I; Mealing S; Carroll S
    BMC Public Health; 2020 Sep; 20(1):1464. PubMed ID: 32993588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. French economic evaluations of influenza and influenza vaccination.
    Levy E
    Pharmacoeconomics; 1996; 9 Suppl 3():62-6. PubMed ID: 10160489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza-related health care utilization and productivity losses during seasons with and without a match between the seasonal and vaccine virus B lineage.
    Karve S; Meier G; Davis KL; Misurski DA; Wang CC
    Vaccine; 2013 Jul; 31(33):3370-88. PubMed ID: 23707697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. US healthcare costs attributable to type A and type B influenza.
    Yan S; Weycker D; Sokolowski S
    Hum Vaccin Immunother; 2017 Sep; 13(9):2041-2047. PubMed ID: 28700268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost for physician-diagnosed influenza and influenza-like illnesses on primary care level in Germany--results of a database analysis from May 2010 to April 2012.
    Ehlken B; Anastassopoulou A; Hain J; Schröder C; Wahle K
    BMC Public Health; 2015 Jun; 15():578. PubMed ID: 26093501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of influenza B: a structured literature review.
    Paul Glezen W; Schmier JK; Kuehn CM; Ryan KJ; Oxford J
    Am J Public Health; 2013 Mar; 103(3):e43-51. PubMed ID: 23327249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study].
    Marcellusi A; Viti R; Incorvaia C; Mennini FS
    Recenti Prog Med; 2015 Oct; 106(10):517-27. PubMed ID: 26442978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.
    Uhart M; Bricout H; Clay E; Largeron N
    Hum Vaccin Immunother; 2016 Sep; 12(9):2259-68. PubMed ID: 27166916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness study on influenza prevention in Hong Kong.
    Fitzner KA; Shortridge KF; McGhee SM; Hedley AJ
    Health Policy; 2001 Jun; 56(3):215-34. PubMed ID: 11399347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and cost of seasonal influenza in Germany - a claims data analysis.
    Scholz S; Damm O; Schneider U; Ultsch B; Wichmann O; Greiner W
    BMC Public Health; 2019 Aug; 19(1):1090. PubMed ID: 31409319
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.